Cancer

  • A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.

  • Screening, treatment halve breast cancer deaths

    Treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019, according to a Stanford Medicine-led study.

  • Tumor DNA levels in blood predict outcome

    Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

  • Scar tissue predicts lifespan

    Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.

  • Cancer neuroscience discoveries give hope

    To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

  • African Americans less likely to be screened

    National guidelines for lung cancer screening are less effective for African Americans than for whites, Stanford study concludes. A risk-based analysis is more equitable and effective.

  • Lung cancer cells protected by brain cells

    Small cell lung cancers often metastasize to the brain. A Stanford Medicine study shows they thrive there by emulating developing neurons and recruiting surrounding cells for protection.

  • Reena Thomas gets $12 million CIRM grant

    The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

  • Arc Institute awards

    Two professors are named Innovation Investigators, and four win Ignite Awards.

  • Big Ideas in Medicine

    Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…

  • Real-time targeting of tumors

    New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

  • AI could inform brain cancer prognosis

    Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.


Related Websites